Cenovus Energy Inc., together with its subsidiaries, develops, produces, refines, transports, and markets crude oil, natural gas, and refined petroleum products in Canada, the United States, and China. It operates through Upstream and Downstream segments. The company is involved in the development and production of bitumen and heavy oil; owns and operates pipeline gathering systems and terminals; operation of assets rich in NGLs and natural gas in Alberta and British Columbia; and offshore operations, exploration, and development activities in the East Coast of Canada and the Asia Pacific region. It also engages in refining, such as owned and operated Lloydminster upgrading and asphalt refining complex; owns and operates the Bruderheim crude-by-rail terminal and two ethanol plants; fuels business; and refining of crude oil to produce gasoline, diesel, jet fuel, asphalt, and other products. Cenovus Energy Inc. was founded in 2009 and is headquartered in Calgary, Canada.…
Here is Why Growth Investors Should Buy Cenovus (CVE) Now
Cenovus Energy (NYSE: CVE) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Oil & Gas Integrated industry, part of the Energy sector, and reports about 7,211 employees.
The shares were at 27.07 USD on 20 November 2026, up 50.1% over 52 weeks. Its 52-week range is 15.63 USD to 34.16 USD: the price is 20.8% below the high and 73.2% above the low.
At a market capitalisation of 48.92B USD, it trades at 8.0 times trailing earnings and 7.7 times forward earnings. The median trailing P/E of its 20 largest Oil & Gas Integrated peers is 8.8, so CVE is valued in line with them. It pays a dividend yielding 2.26% (it pays out 18% of its earnings), against a median of 4.13% among the dividend payers in that peer group.
Cenovus Energy reports return on equity of 12.4%, an operating margin of 20.7% and revenue up 21.1% year over year.
Its debt exceeds its cash by 6.00B CAD, a debt-to-equity ratio of 0.45. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 37.66 USD is 39.1% above the current price. The next earnings report is expected on 18 February 2027.